Truist lowered the firm’s price target on Veeva to $187 from $227 and keeps a Hold rating on the shares. The analyst notes that the updated price target assumes a 25-times expected 2025 EBITDA estimate vs. 30-times prior view and also reflects the broader market volatility and incremental risk around further slowdown in the company’s services business.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on VEEV:
- Veeva price target lowered to $160 from $181 at Morgan Stanley
- Doximity price target raised to $21 from $20 at BofA
- Veeva price target lowered to $205 from $211 at Stifel
- Veeva price target lowered to $232 from $242 at Baird
- Veeva price target lowered to $200 from $220 at BofA
Questions or Comments about the article? Write to editor@tipranks.com